Topiramate Overdose: A Case Report and Literature Review

Epilepsy and Behavior

Volumn 2, Issue 6, 2001, Pages 603-607

  Smith, Amanda G ^a   Brauer, Heidi R ^a   Catalano, Glenn ^a   Catalano, Maria C ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antiepileptic medications; Overdose; Poisoning; Side effects; Topiramate; Toxicity

Indexed keywords

EID: 0040927435     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1006/ebeh.2001.0299     Document Type: Article

References (27)

1. Markind J E. Topiramate: a new antiepileptic drug. Am J Health Syst Pharm. 55:1998;554-562.
2. Shank R, Gardocki J, Vaught J. Topiramate: preclinical evaluation of a structurally novel anticonvulsant. Epilepsia. 35:1994;450-460.
3. Glauser T A. Topiramate. Epilepsia. 40:1999;71-80.
4. Ben-Menachem E, Henriksen O, Dam M, Mikkelsen M, Schmidt D, Reid S, Reife R, Kramer L, Pledger G, Karim R. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia. 37:1996;539-543.
5. Bruni J. Efficacy of topiramate. Can J Neurol Sci. 25:1998;6-7.
6. Bourgeois B FD. Drug interaction profile of topiramate. Epilepsia. 37:1996;14-17.
7. Marcotte D. Use of topiramate, a new anti-epileptic as a mood stabilizer. J Affect Disord. 50:1998;245-251.
8. Chengappa K N, Rathore D, Levine J. Topiramate as add-on treatment for patients with bipolar mania. Bipolar Disorders. 1:1999;42-53.
9. Nieto-Barrera M, Candau R, Nieto-Jimenez M, Correa A, del Portal L R. Topiramate in the treatment of severe myoclonic epilepsy in infancy. Seizure. 9:2000;590-594.
10. Wheeler S D, Carrazana E J. Topiramate-treated cluster headache. Neurology. 53:1999;234-236.
11. Tremont-Lukats I W, Megeff C, Backonja M M. Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy. Drugs. 60:2000;1029-1052.
12. Privitera M D. Topiramate: a new antiepileptic drug. Ann Pharmacother. 31:1997;1164-1173.
13. Jones M W. Topiramate - safety and tolerability. Can J Neurol Sci. 25:1998;13-15.
14. Shorvon S D. Safety of topiramate: adverse events and relationships to dosing. Epilepsia. 37:1996;18-22.
15. Aldencamp A P, Baker G, Mulder O G. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia. 41:2000;1167-1178.
16. Gerber P E, Hamiwka L, Connolly M B, Farrell K. Factors associated with behavioral and cognitive abnormalities in children receiving topiramate. Pediatr Neurol. 22:2000;200-203.
17. Dursun S M, Devarajan S. Clozapine weight gain, plus topiramate weight loss. Can J Psychiatry. 45:2000;198.
18. Physicians' Desk Reference. 2001;Medical Economics Company, Inc. New Jersey. p. 2391-6.
19. Tomson T, Johannessen S I. Therapeutic monitoring of the new antiepileptic drugs. Eur J Clin Pharmacol. 55:2000;697-705.
20. Perruca E, Bialer M. The clinical pharmacokinetics of the newer antiepileptic drugs. Focus on topiramate, zonisamide and tiagabine. Clin Pharmacokinet. 31:1996;29-46.
21. Package Insert-Topamax® (topiramate) Tablets and Topamax® (topiramate capsules) Sprinkle Capsules, Ortho-McNeil Pharmaceutical Inc, Raritan, NJ, 08869.
22. Nayak R K, Gisclon L G, Curtin D A, Benet L Z. Estimation of the absolute bioavailability of topiramate in humans without intravenous data. J Clin Pharmacol. 34:1994;1029.
23. Easterling D E, Zakszewski T, Moyer M D, Margul B L, Marriott T B, Nayak R K. Plasma pharmacokinetics of topiramate, a new anticonvulsant in humans. Epilepsia. 29:1988;552.
24. Garnett W R. Clinical pharmacology of topiramate: a review. Epilepsia. 41:2000;61-65.
25. Doose D R, Gisclon L G, Stellar S M, Riffits J M, Hills J F. The effect of food on the bioavailability of topiramate from 100 and 400 mg tablets in healthy male subjects. Epilepsia. 33:1992;105.
26. Schneiderman J H. Topiramate: pharmacokinetics and pharmacodynamics. Can J Neurol Sci. 25:1998;3-5.
27. Winter M E. Clinical Pharmacokinetics. Lloyd Y Y, Koda-Kimble M A. Applied Therapeutics: The Clinical Use of Drugs. 1988;1-14 Applied Therapeutics, Inc. Vancouver.